Literature DB >> 19748670

Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.

Joana Santos1, Nuno Cerveira, Susana Bizarro, Franclim R Ribeiro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, José M Mariz, Lucília Norton, Simone Snijder, Clemens H Mellink, Arjan Buijs, Lee-Yung Shih, Sabine Strehl, Francesca Micci, Sverre Heim, Manuel R Teixeira.   

Abstract

Septins are proteins associated with crucial steps in cell division and cellular integrity. In humans, 14 septin genes have been identified, of which five (SEPT2, SEPT5, SEPT6, SEPT9, and SEPT11) are known to participate in reciprocal translocations with the MLL gene in myeloid neoplasias. We have recently shown a significant down-regulation of both SEPT2 and MLL in myeloid neoplasias with the MLL-SEPT2 fusion gene. In this study, we examined the expression pattern of the other 13 known septin genes in altogether 67 cases of myeloid neoplasia, including three patients with the MLL-SEPT2 fusion gene, four with MLL-SEPT6 fusion, and three patients with the MLL-SEPT9 fusion gene. When compared with normal controls, a statistically significant down-regulation was observed for the expression of both MLL (6.4-fold; p=0.008) and SEPT6 (1.7-fold; p=0.002) in MLL-SEPT6 leukemia. Significant down-regulation of MLL was also found in MLL-MLLT3 leukemias. In addition, there was a trend for SEPT9 down-regulation in MLL-SEPT9 leukemias (4.6-fold; p=0.077). Using hierarchical clustering analysis to compare acute myeloid leukemia genetic subgroups based on their similarity of septin expression changes, we found that MLL-SEPT2 and MLL-SEPT6 neoplasias cluster together apart from the remaining subgroups and that PML-RARA leukemia presents under-expression of most septin family genes. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748670     DOI: 10.1016/j.leukres.2009.08.018

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Sept4/ARTS is required for stem cell apoptosis and tumor suppression.

Authors:  María García-Fernández; Holger Kissel; Samara Brown; Travis Gorenc; Andrew J Schile; Shahin Rafii; Sarit Larisch; Hermann Steller
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

2.  Congenital X-linked neutropenia with myelodysplasia and somatic tetraploidy due to a germline mutation in SEPT6.

Authors:  Raffaele Renella; Katelyn Gagne; Ellen Beauchamp; Jonathan Fogel; Aleksej Perlov; Mireia Sola; Thorsten Schlaeger; Inga Hofmann; Akiko Shimamura; Benjamin L Ebert; Klaus Schmitz-Abe; Kyriacos Markianos; Kristi Murphy; Liang Sun; Shira Rockowitz; Piotr Sliz; Dean R Campagna; Timothy A Springer; Christopher Bahl; Suneet Agarwal; Mark D Fleming; David A Williams
Journal:  Am J Hematol       Date:  2021-11-03       Impact factor: 10.047

3.  Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.

Authors:  Camila Prieto; Diu T T Nguyen; Zhaoqi Liu; Justin Wheat; Alexendar Perez; Saroj Gourkanti; Timothy Chou; Ersilia Barin; Anthony Velleca; Thomas Rohwetter; Arthur Chow; James Taggart; Angela M Savino; Katerina Hoskova; Meera Dhodapkar; Alexandra Schurer; Trevor S Barlowe; Ly P Vu; Christina Leslie; Ulrich Steidl; Raul Rabadan; Michael G Kharas
Journal:  Nat Cancer       Date:  2021-07-05

4.  Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.

Authors:  Andrea Pellagatti; Richard N Armstrong; Violetta Steeples; Eshita Sharma; Emmanouela Repapi; Shalini Singh; Andrea Sanchi; Aleksandar Radujkovic; Patrick Horn; Hamid Dolatshad; Swagata Roy; John Broxholme; Helen Lockstone; Stephen Taylor; Aristoteles Giagounidis; Paresh Vyas; Anna Schuh; Angela Hamblin; Elli Papaemmanuil; Sally Killick; Luca Malcovati; Marco L Hennrich; Anne-Claude Gavin; Anthony D Ho; Thomas Luft; Eva Hellström-Lindberg; Mario Cazzola; Christopher W J Smith; Stephen Smith; Jacqueline Boultwood
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

5.  High SEPT9_i1 protein expression is associated with high-grade prostate cancers.

Authors:  Roni Gilad; Karen Meir; Ilan Stein; Larissa German; Eli Pikarsky; Nicola J Mabjeesh
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

6.  Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis.

Authors:  Roxane L Degroote; Stefanie M Hauck; Barbara Amann; Sieglinde Hirmer; Marius Ueffing; Cornelia A Deeg
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

7.  Comparative expression analysis of Septin 14 in testes of infertile men with normal spermatogenesis and spermatogenic failure.

Authors:  Maryam Shafipour; Marjan Sabbaghian; Maryam Shahhoseini; Mohammad Ali Sadighi Gilani
Journal:  Iran J Reprod Med       Date:  2014-03

8.  Acute myeloid leukemia with KMT2A-SEPT5 translocation: A case report and review of the literature.

Authors:  Shaimaa Elzamly; Santosh Chavali; Vijay Tonk; Sahil Tonk; Sumit Gaur; Darlene Tarango; Alireza Torabi
Journal:  SAGE Open Med Case Rep       Date:  2018-01-04

9.  MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11).

Authors:  Duobing Zou; Ying Chen; Ningning Wu; Yi Zhang; Guifang Ouyang; Qitian Mu
Journal:  Front Med (Lausanne)       Date:  2021-12-22

10.  Mitochondria mediate septin cage assembly to promote autophagy of Shigella.

Authors:  Andrea Sirianni; Sina Krokowski; Damián Lobato-Márquez; Stephen Buranyi; Julia Pfanzelter; Dieter Galea; Alexandra Willis; Siân Culley; Ricardo Henriques; Gerald Larrouy-Maumus; Michael Hollinshead; Vanessa Sancho-Shimizu; Michael Way; Serge Mostowy
Journal:  EMBO Rep       Date:  2016-06-03       Impact factor: 9.071

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.